Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Other
  • S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer
  • Other

S16 Ep55: OncoBytes Adaptive Learning Pathways: Personalizing Treatment Plans to Optimize Adjuvant Therapy in Early-Stage HR+/HER2- Breast Cancer

OncLive Podcast

In this podcast, experts Joyce O'Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A.

OtherOncologyRead full story

pharminent April 20, 2026 (Last updated: April 20, 2026)

OncLive Podcast

In this podcast, experts Joyce O’Shaughnessy, MD; Virginia Kaklamani, MD, DSc; and Seth A.

OtherOncologyRead full story

Post navigation

Previous: Beyond GLP-1Rs: emerging targets poised to gain share of obesity market
Next: Novo’s late-stage sickle cell win piles pressure on competitors

Related Stories

  • Other

Takeda and Weave Bio collaborate on AI-driven automation in drug development

pharminent September 2, 2026
  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.